Frederick W Gluck - Net Worth and Insider Trading
Frederick W Gluck Net Worth
The estimated net worth of Frederick W Gluck is at least $5 Million dollars as of 2024-11-10. Frederick W Gluck is the Director of Amgen Inc and owns about 15,748 shares of Amgen Inc (AMGN) stock worth over $5 Million. Frederick W Gluck is also the Director of CytomX Therapeutics Inc and owns about 296,954 shares of CytomX Therapeutics Inc (CTMX) stock worth over $323,680. Details can be seen in Frederick W Gluck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frederick W Gluck has not made any transactions after 2018-03-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frederick W Gluck
Frederick W Gluck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frederick W Gluck owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , Amgen Inc (AMGN) , and HCA Healthcare Inc (HCA) .
Click here to see the complete history of Frederick W Gluck’s form 4 insider trades.
Insider Ownership Summary of Frederick W Gluck
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-06-13 | director |
| AMGN | Amgen Inc | 2010-09-08 | director |
| HCA | HCA Healthcare Inc | 2003-07-24 | director |
Frederick W Gluck Latest Holdings Summary
Frederick W Gluck currently owns a total of 2 stocks. Among these stocks, Frederick W Gluck owns 15,748 shares of Amgen Inc (AMGN) as of September 8, 2010, with a value of $5 Million and a weighting of 94.06%. Frederick W Gluck also owns 296,954 shares of CytomX Therapeutics Inc (CTMX) as of March 26, 2018, with a value of $323,680 and a weighting of 5.94%.
Latest Holdings of Frederick W Gluck
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | 2010-09-08 | 15,748 | 325.28 | 5,122,509 |
| CTMX | CytomX Therapeutics Inc | 2018-03-26 | 296,954 | 1.09 | 323,680 |
Holding Weightings of Frederick W Gluck
Frederick W Gluck Form 4 Trading Tracker
According to the SEC Form 4 filings, Frederick W Gluck has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 800 shares on September 8, 2010, which brought Frederick W Gluck around $41,888.
According to the SEC Form 4 filings, Frederick W Gluck has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 5,000 shares on March 26, 2018, which brought Frederick W Gluck around $159,650.
Insider Trading History of Frederick W Gluck
- 1
Frederick W Gluck Trading Performance
GuruFocus tracks the stock performance after each of Frederick W Gluck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frederick W Gluck is -1.38%. GuruFocus also compares Frederick W Gluck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frederick W Gluck within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frederick W Gluck's insider trading performs compared to the benchmark.
Performance of Frederick W Gluck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.15 | | | | | |
| Relative Return to S&P 500(%) | -5.65 | | | | | |
Frederick W Gluck Ownership Network
Ownership Network List of Frederick W Gluck
Ownership Network Relation of Frederick W Gluck
Frederick W Gluck Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Frederick W Gluck is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Frederick W Gluck made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Frederick W Gluck Mailing Address
Above is the net worth, insider trading, and ownership report for Frederick W Gluck. You might contact Frederick W Gluck via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
